drugset / Trial / NCT04620382
Effect of Midodrine vs Abdominal Compression on Cardiovascular Risk Markers in Autonomic Failure Patients
Phase 0
Completed
31 enrolled
Vanderbilt University Medical Center
National Heart, Lung, and Blood Institute (NHLBI) · collab
RandomizedCrossoverSingle-blindOther
Summary
The purpose of this study is to learn more about the effects of abdominal compression and the medication midodrine, two interventions used for the treatment of orthostatic hypotension (low blood pressure on standing), on hemodynamic markers of cardiovascular risk. The study will be conducted at the Vanderbilt University Medical Center and consists of a screening and 2 testing days, one with abdominal compression and one with midodrine. The total length of the study will be about 5 days.
Timeline
- Start
- 2020-11-09
- Primary completion
- 2025-07-01
- Completion
- 2025-12-01